Methyl 4-(2-((3-(4-chlorophenyl)-4-oxo-3,4,5,6,7,8-hexahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)acetamido)benzoate

Catalog No. :
ACPVAC218
CAS No. :
618432-07-8
Molecular Formula :
C26H22ClN3O4S2
Molecular Weight :
540.07

IUPAC Name:methyl 4-(2-((3-(4-chlorophenyl)-4-oxo-3,4,5,6,7,8-hexahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)acetamido)benzoate

Methyl 4-(2-((3-(4-chlorophenyl)-4-oxo-3,4,5,6,7,8-hexahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)acetamido)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-(2-((3-(4-chlorophenyl)-4-oxo-3,4,5,6,7,8-hexahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)acetamido)benzoate
IUPAC Namemethyl 4-(2-((3-(4-chlorophenyl)-4-oxo-3,4,5,6,7,8-hexahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)acetamido)benzoate
Molecular FormulaC26H22ClN3O4S2
Molecular Weight540.07
SMILESO=C(OC)C1=CC=C(NC(CSC2=NC3=C(C4=C(CCCC4)S3)C(N2C5=CC=C(Cl)C=C5)=O)=O)C=C1
InChI KeyQQIGJMPTIXUMQA-UHFFFAOYSA-N
SynonymMETHYL 4-[(([3-(4-CHLOROPHENYL)-4-OXO-3,4,5,6,7,8-HEXAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-2-YL]SULFANYL)ACETYL)AMINO]BENZOATE;SALOR-INT L416428-1EA
CAS No.618432-07-8

Synthetic Route by SureRoute

1. ACPVAC218 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAQXN128 route compound structure diagram
    ACAQXN128619-45-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPVAC218 route product structure diagram
    ACPVAC218618432-07-8
Inquiry

2. ACPVAC218 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPVAC218 route product structure diagram
    ACPVAC218618432-07-8
Inquiry

Comments (0)